Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-14-011440
Filing Date
2014-07-03
Accepted
2014-07-03 13:31:31
Documents
1
Period of Report
2014-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 17146
  Complete submission text file 0001179110-14-011440.txt   18354
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Gollust Keith R (Reporting) CIK: 0001325712 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 14959920